Revolution Medicines, Inc. (NASDAQ:RVMD) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Revolution Medicines, Inc. (NASDAQ: RVMD) had its price target raised by analysts at Wedbush from $42.00 to $46.00. They now have an "outperform" rating on the stock.
Revolution Medicines, Inc. (NASDAQ: RVMD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $46.00 price target on the stock.
Revolution Medicines Reports First Quarter 2024 Financial Results and Update on Corporate Progress [Yahoo! Finance]
Revolution Medicines Reports First Quarter 2024 Financial Results and Update on Corporate Progress